Wooree Bio Co.Ltd (082850) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wooree Bio Co.Ltd (082850) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.99 Billion ≈ $10.16 Million USD) by net assets (₩261.34 Billion ≈ $177.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wooree Bio Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Wooree Bio Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 082850 total liabilities for a breakdown of total debt and financial obligations.
Wooree Bio Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wooree Bio Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Urja Global Limited
NSE:URJA
|
-0.086x |
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
0.011x |
|
Kukje Pharma Co Ltd
KO:002720
|
0.052x |
|
Everest Industries Limited
NSE:EVERESTIND
|
-0.029x |
|
Linc Limited
NSE:LINC
|
0.108x |
|
Gedeon Richter PLC
LSE:0QFP
|
0.038x |
|
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA
|
0.499x |
|
GameSparcs Co Ltd
TWO:6542
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Wooree Bio Co.Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Wooree Bio Co.Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Wooree Bio Co.Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩261.34 Billion ≈ $177.11 Million |
₩34.82 Billion ≈ $23.60 Million |
0.133x | -22.00% |
| 2024-12-31 | ₩212.13 Billion ≈ $143.76 Million |
₩36.24 Billion ≈ $24.56 Million |
0.171x | +61.79% |
| 2023-12-31 | ₩251.10 Billion ≈ $170.17 Million |
₩26.51 Billion ≈ $17.97 Million |
0.106x | -56.40% |
| 2022-12-31 | ₩179.01 Billion ≈ $121.32 Million |
₩43.35 Billion ≈ $29.38 Million |
0.242x | -25.27% |
| 2021-12-31 | ₩154.94 Billion ≈ $105.00 Million |
₩50.21 Billion ≈ $34.03 Million |
0.324x | -48.12% |
| 2020-12-31 | ₩111.15 Billion ≈ $75.32 Million |
₩69.43 Billion ≈ $47.05 Million |
0.625x | -11.38% |
| 2019-12-31 | ₩93.36 Billion ≈ $63.27 Million |
₩65.80 Billion ≈ $44.59 Million |
0.705x | +473.05% |
| 2018-12-31 | ₩88.00 Billion ≈ $59.64 Million |
₩10.82 Billion ≈ $7.34 Million |
0.123x | -42.35% |
| 2017-12-31 | ₩129.96 Billion ≈ $88.08 Million |
₩27.73 Billion ≈ $18.79 Million |
0.213x | +1512.77% |
| 2016-12-31 | ₩129.01 Billion ≈ $87.43 Million |
₩-1.95 Billion ≈ $-1.32 Million |
-0.015x | +84.57% |
| 2015-12-31 | ₩126.89 Billion ≈ $85.99 Million |
₩-12.42 Billion ≈ $-8.42 Million |
-0.098x | -144.79% |
| 2014-12-31 | ₩248.46 Billion ≈ $168.38 Million |
₩54.31 Billion ≈ $36.81 Million |
0.219x | -23.66% |
| 2013-12-31 | ₩282.03 Billion ≈ $191.13 Million |
₩80.75 Billion ≈ $54.72 Million |
0.286x | +667.80% |
| 2011-12-31 | ₩224.31 Billion ≈ $152.01 Million |
₩8.36 Billion ≈ $5.67 Million |
0.037x | -46.71% |
| 2010-12-31 | ₩247.65 Billion ≈ $167.83 Million |
₩17.33 Billion ≈ $11.74 Million |
0.070x | -69.72% |
| 2009-12-31 | ₩201.66 Billion ≈ $136.66 Million |
₩46.60 Billion ≈ $31.58 Million |
0.231x | -54.24% |
| 2008-12-31 | ₩137.18 Billion ≈ $92.97 Million |
₩69.27 Billion ≈ $46.94 Million |
0.505x | -- |
About Wooree Bio Co.Ltd
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; surface mounting technology products; separators for secondary batteries; backlight parts for thin film transistor-liquid crystal displays; sells and assembles TVs; and TV and LCD monitor components. In addition, it pro… Read more